China SXT Pharmaceuticals, Inc. (SXTC)Healthcare | Drug Manufacturers - Specialty & Generic | Taizhou, China | NasdaqCM
2.55 USD
-0.01
(-0.391%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 2.49 -0.06 (-0.060%) ⇩ (July 13, 2026, 5:29 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 3:48 a.m. EDT
The investment case here is fundamentally broken. The business is hemorrhaging cash with negative operating cash flow and free cash flow, while revenue has contracted by nearly 44% year-over-year. The balance sheet is fragile, showing negative returns on both assets and equity, indicating the company is destroying value rather than generating it. While the stock price recently staged a massive recovery from its historical lows—jumping from a fraction of a cent to over $2—the underlying economics remain dire. This price surge appears to be a speculative re-rating based on capital raising activities rather than operational improvement. The recent news of massive share offerings and reclassifications suggests the company is desperate for liquidity, which often precedes further dilution. With no dividend to provide income and a trajectory of shrinking revenues and mounting losses, there is no margin of safety for a long-term holder. The short-term outlook remains precarious given the weak statistical forecast and the inherent risks of a distressed biotech firm relying on equity markets to stay afloat. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.175559 |
| MSTL | 0.179361 |
| AutoETS | 0.183014 |
| AutoTheta | 0.183087 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 0.87 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.085 |
| Excess Kurtosis | -1.34 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.773 |
| Revenue per Share | 1.674 |
| Market Cap | 97,456,104 |
| Beta | 1.82 |
| Website | https://www.sxtchina.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.989759 |
| Address1 | 178 Taidong Road North |
| All Time High | 350,250.0 |
| All Time Low | 1.25 |
| Ask | 3.2 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 59,300 |
| Average Daily Volume3 Month | 66,834 |
| Average Volume | 66,834 |
| Average Volume10Days | 59,300 |
| Beta | 1.817 |
| Bid | 1.83 |
| Bid Size | 2 |
| Book Value | 26.158 |
| City | Taizhou |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | China |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.55 |
| Current Ratio | 7.935 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 2.62 |
| Day Low | 2.48 |
| Debt To Equity | 3.773 |
| Display Name | China SXT Pharmaceuticals |
| Ebitda | -7,049,265 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -7.796 |
| Enterprise To Revenue | 48.29 |
| Enterprise Value | 54,956,256 |
| Eps Trailing Twelve Months | -9.09 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.96816 |
| Fifty Day Average Change | 0.5818399 |
| Fifty Day Average Change Percent | 0.2956263 |
| Fifty Two Week Change Percent | -98.97591 |
| Fifty Two Week High | 1,047.0 |
| Fifty Two Week High Change | -1,044.45 |
| Fifty Two Week High Change Percent | -0.99756444 |
| Fifty Two Week Low | 1.25 |
| Fifty Two Week Low Change | 1.3 |
| Fifty Two Week Low Change Percent | 1.04 |
| Fifty Two Week Range | 1.25 - 1047.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,546,612,200,000 |
| Float Shares | 31,944,872 |
| Free Cashflow | -4,736,071 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 56 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.21853 |
| Gross Profits | 248,702 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 1.09483 |
| Held Percent Institutions | 0.00243 |
| Implied Shares Outstanding | 38,218,081 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Language | en-US |
| Last Fiscal Year End | 1,774,915,200 |
| Last Split Date | 1,770,076,800 |
| Last Split Factor | 1:150 |
| Long Business Summary | China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China. |
| Long Name | China SXT Pharmaceuticals, Inc. |
| Market | us_market |
| Market Cap | 97,456,104 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_545675635 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -6,205,085 |
| Next Fiscal Year End | 1,806,451,200 |
| Non Diluted Market Cap | 97,456,106 |
| Open | 2.62 |
| Operating Cashflow | -4,017,456 |
| Operating Margins | -1.53282 |
| Payout Ratio | 0.0 |
| Phone | 86 523 8629 8290 |
| Post Market Change | -0.059999943 |
| Post Market Change Percent | -2.352939 |
| Post Market Price | 2.49 |
| Post Market Time | 1,783,978,152 |
| Previous Close | 2.56 |
| Price Hint | 4 |
| Price To Book | 0.097484514 |
| Price To Sales Trailing12 Months | 85.63414 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.232 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.39062464 |
| Regular Market Day High | 2.62 |
| Regular Market Day Low | 2.48 |
| Regular Market Day Range | 2.48 - 2.62 |
| Regular Market Open | 2.62 |
| Regular Market Previous Close | 2.56 |
| Regular Market Price | 2.55 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 3,967 |
| Return On Assets | -0.15782 |
| Return On Equity | -0.27488002 |
| Revenue Growth | -0.439 |
| Revenue Per Share | 1.674 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 38,218,077 |
| Shares Percent Shares Out | 0.0014 |
| Shares Short | 45,019 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 5,151 |
| Short Name | China SXT Pharmaceuticals, Inc. |
| Short Percent Of Float | 0.0014 |
| Short Ratio | 0.32 |
| Source Interval | 15 |
| Symbol | SXTC |
| Total Cash | 28,320,836 |
| Total Cash Per Share | 0.879 |
| Total Debt | 1,120,986 |
| Total Revenue | 1,138,052 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -9.09 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 85.30881 |
| Two Hundred Day Average Change | -82.758804 |
| Two Hundred Day Average Change Percent | -0.97010857 |
| Type Disp | Equity |
| Volume | 3,967 |
| Website | https://www.sxtchina.com |
| Zip | 225,300 |